Determining risk features for medulloblastoma in the molecular era.
作者信息
Gottardo Nicholas G, Gajjar Amar
机构信息
Department of Pediatric and Adolescent Oncology and Hematology, Perth Children's Hospital, Perth, Western Australia, Australia.
Brain Tumor Research Program, Kids Cancer Centre, The Kids Research Institute Australia, University of Western Australia, Perth, Western Australia, Australia.
出版信息
Neuro Oncol. 2025 Jan 12;27(1):219-221. doi: 10.1093/neuonc/noae223.
Abstract
摘要
相似文献
1
Determining risk features for medulloblastoma in the molecular era.确定分子时代髓母细胞瘤的风险特征。
Neuro Oncol. 2025 Jan 12;27(1):219-221. doi: 10.1093/neuonc/noae223.
2
Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era.分子时代的癌症易感性综合征与髓母细胞瘤
Front Oncol. 2020 Oct 29;10:566822. doi: 10.3389/fonc.2020.566822. eCollection 2020.
3
Medulloblastoma genomics in the modern molecular era.现代分子时代的髓母细胞瘤基因组学。
Brain Pathol. 2020 May;30(3):679-690. doi: 10.1111/bpa.12804. Epub 2019 Dec 16.
4
Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management.现代时代的髓母细胞瘤：当代试验、分子进展回顾和治疗更新。
Neurotherapeutics. 2022 Oct;19(6):1733-1751. doi: 10.1007/s13311-022-01273-0. Epub 2022 Jul 20.
5
Medulloblastoma: "Onset of the molecular era".髓母细胞瘤：“分子时代的开端”。
Mol Biol Rep. 2020 Dec;47(12):9931-9937. doi: 10.1007/s11033-020-05971-w. Epub 2020 Nov 6.
6
Evolving molecular era of childhood medulloblastoma: time to revisit therapy.儿童髓母细胞瘤不断发展的分子时代：是时候重新审视治疗方法了。
Future Oncol. 2016 Jan;12(1):107-17. doi: 10.2217/fon.15.284. Epub 2015 Nov 30.
7
Pediatric medulloblastoma in the molecular era: what are the surgical implications?分子时代的小儿髓母细胞瘤：手术有哪些影响？
Cancer Metastasis Rev. 2020 Mar;39(1):235-243. doi: 10.1007/s10555-020-09865-y.
8
New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.分子肿瘤学时代成人髓母细胞瘤治疗的新视角。
Crit Rev Oncol Hematol. 2015 Jun;94(3):348-59. doi: 10.1016/j.critrevonc.2014.12.016. Epub 2014 Dec 31.
9
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.分子时代儿童髓母细胞瘤的风险分层：当前共识
Acta Neuropathol. 2016 Jun;131(6):821-31. doi: 10.1007/s00401-016-1569-6. Epub 2016 Apr 4.
10
Mini-symposium in medulloblastoma genomics in the modern molecular era.现代分子时代髓母细胞瘤基因组学小型研讨会
Brain Pathol. 2020 May;30(3):661-663. doi: 10.1111/bpa.12838.
本文引用的文献
1
Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtype.米兰超分割加速放疗策略用于高危髓母细胞瘤的长期预后，包括分子亚型的影响。
Neuro Oncol. 2025 Jan 12;27(1):209-218. doi: 10.1093/neuonc/noae189.
2
Verschlimmbesserung: Craniospinal Radiotherapy Is Essential in WNT Medulloblastoma Patients.恶化：颅脊髓放疗是 WNT 型髓母细胞瘤患者的必要治疗。
Clin Cancer Res. 2023 Dec 15;29(24):4996-4998. doi: 10.1158/1078-0432.CCR-23-2331.
3
Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial.高危髓母细胞瘤的临床试验：欧洲小儿肿瘤协作组-欧洲高危髓母细胞瘤试验的进展
Cancers (Basel). 2022 Jan 13;14(2):374. doi: 10.3390/cancers14020374.
4
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.髓母细胞瘤液体活检中可测量残留病灶的连续评估。
Cancer Cell. 2021 Nov 8;39(11):1519-1530.e4. doi: 10.1016/j.ccell.2021.09.012. Epub 2021 Oct 21.
5
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.卡铂和异维 A 酸治疗高危型髓母细胞瘤患儿的疗效：一项来自儿童肿瘤学组的随机临床试验。
JAMA Oncol. 2021 Sep 1;7(9):1313-1321. doi: 10.1001/jamaoncol.2021.2224.
6
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).调整风险适应治疗的儿童髓母细胞瘤的临床和分子特征的结果：一项国际 III 期试验（SJMB03）的结果。
J Clin Oncol. 2021 Mar 1;39(7):822-835. doi: 10.1200/JCO.20.01372. Epub 2021 Jan 6.
7
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.儿童髓母细胞瘤临床分类及预后预测的新型分子亚组：一项队列研究
Lancet Oncol. 2017 Jul;18(7):958-971. doi: 10.1016/S1470-2045(17)30243-7. Epub 2017 May 22.
8
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.儿童和青少年转移性髓母细胞瘤的治疗及临床和生物学参数的预后相关性。
J Clin Oncol. 2016 Dec;34(34):4151-4160. doi: 10.1200/JCO.2016.67.2428. Epub 2016 Oct 31.
9
Cytogenetic prognostication within medulloblastoma subgroups.在髓母细胞瘤亚组中进行细胞遗传学预后评估。
J Clin Oncol. 2014 Mar 20;32(9):886-96. doi: 10.1200/JCO.2013.50.9539. Epub 2014 Feb 3.
10
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.髓母细胞瘤的分子亚型：WNT、SHH、Group 3 和 Group 4 髓母细胞瘤的转录组、遗传异常和临床数据的国际荟萃分析。
Acta Neuropathol. 2012 Apr;123(4):473-84. doi: 10.1007/s00401-012-0958-8. Epub 2012 Feb 23.
Zotero 插件